GL1X · GenesisL1 explorer

Ligand · 8DE

8DE · 2,2-diphenyl-~{N}-[4-(1,3-thiazol-2-ylsulfamoyl) phenyl]ethanamide

8DE, 2,2-diphenyl-~{N}-[4-(1,3-thiazol-2-ylsulfamoyl) phenyl]ethanamide (C23 H19 N3 O3 S2, 449.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…

Component
8DE
Formula
C23 H19 N3 O3 S2
Class
ligand
Structures
2
PDB entries
1

Binding sites

8DE in 2 structures; the first of them:

  • 7W7F · Cryo-EM structure of human NaV1.3/beta1/beta2-ICA121431 · 8DE D2103 · binds SER1559, ASN1562, LEU1563, SER1600, GLY1603, MET1604, ALA1607, GLU1608 and 4 more
  • 7W7F · Cryo-EM structure of human NAV1.3/BETA1/BETA2-ICA121431 · 8DE D2103 · binds SER1559, ASN1562, LEU1563, SER1600, GLY1603, MET1604, ALA1607, GLU1608 and 4 more

Residues it binds most

ARG 2, ALA 2, SER 2, ASN 2, GLU 2, GLY 2, LEU 2, MET 2 (residue and the binding sites it lines).

Found with

  • 6OU · [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate
  • 9Z9 · (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en
  • BMA · beta-D-mannopyranose
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.